Results 41 to 50 of about 53,297 (154)

MOESM6 of α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb

open access: yes, 2019
Additional file 6. Microglial morphology analysis reveals no differences in microglial activation between groups.
Rey, Nolwen   +8 more
openaire   +1 more source

α-synuclein strains that cause distinct pathologies differentially inhibit proteasome

open access: yeseLife, 2020
Abnormal α-synuclein aggregation has been implicated in several diseases and is known to spread in a prion-like manner. There is a relationship between protein aggregate structure (strain) and clinical phenotype in prion diseases, however, whether ...
Genjiro Suzuki   +7 more
doaj   +1 more source

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND:Cerebrospinal fluid (CSF) α-synuclein is reduced in synucleinopathies, including dementia with Lewy bodies, and some studies have found increased CSF α-synuclein in Alzheimer's disease (AD).
Niklas Mattsson   +7 more
doaj   +1 more source

MOESM2 of α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb

open access: yes, 2019
Additional file 2. List of antibodies, references and working concentrations.
Rey, Nolwen   +8 more
openaire   +1 more source

Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease

open access: yesNeurobiology of Disease, 2013
Alpha-synuclein phosphorylated at serine 129 (S129) is highly elevated in Parkinson's disease patients where it mainly accumulates in the Lewy bodies. Several groups have studied the role of phosphorylation at the S129 in α-synuclein in a rat model for ...
Fabia Febbraro   +6 more
doaj   +1 more source

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy. [PDF]

open access: yesPLoS ONE, 2013
Neurosin is a protease that in vitro degrades α-synuclein, the main constituent of Lewy bodies found in brains of patients with synucleinopathy including Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
Malin Wennström   +7 more
doaj   +1 more source

MOESM5 of α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb

open access: yes, 2019
Additional file 5. Negative binomial mixed-effects model analysis of pser129 quantifications.
Rey, Nolwen   +8 more
openaire   +1 more source

Neuroprotective function of Omi to α-synuclein-induced neurotoxicity

open access: yesNeurobiology of Disease, 2020
Astract: The main pathological hallmark of Parkinson's disease (PD) is the presence of Lewy bodies, which mainly consist of aggregated α-synuclein. Based on the neurotoxicity of oligomeric α-synuclein and its significance in the aetiology of PD, there ...
Hea-Jong Chung   +3 more
doaj   +1 more source

Proteasome impairment by α-synuclein. [PDF]

open access: yesPLoS ONE, 2017
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide and characterized by the loss of dopaminergic neurons in the patients' midbrains.
Lisa Zondler   +8 more
doaj   +1 more source

Modelling α-synuclein processing in primary patient cells for pharmacological intervention

open access: yesExploration of Medicine, 2023
Aim: Parkinson’s disease (PD) is a complex, chronic neurodegenerative disorder with predominately sporadic etiology. Intricate genetic-environmental interactions lead to the hallmarks of the disease: degeneration of dopaminergic neurons and the ...
Jessica K. Smith   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy